Table 2.
Group | n | Infection of skin redness and swelling after administration |
|||||
---|---|---|---|---|---|---|---|
Day 1 | Day 2 | Day 3 | Day 6 | Day 12 | Day 18 | ||
Blank group | 6 | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 | 0 ± 0 |
Model group | 6 | 1 ± 0 | 1.33 ± 0.52 | 1.50 ± 0.55 | 1.00 ± 0.63 | 0.17 ± 0.41 | 0.17 ± 0.41 |
Jingwanhonggroup | 6 | 1 ± 0 | 1 ± 0 | 1 ± 0* | 0.50 ± 0.55 | 0 ± 0 | 0 ± 0 |
High dose of nano-silver hydrogel coating film group | 6 | 1 ± 0 | 1 ± 0 | 1 ± 0* | 0 ± 0** | 0 ± 0 | 0 ± 0 |
Medium dose of nano-silver hydrogel coating film group | 6 | 1 ± 0 | 1 ± 0 | 1 ± 0* | 0.17 ± 0.41* | 0 ± 0 | 0 ± 0 |
Low dose of nano-silver hydrogel coating film group | 6 | 1 ± 0 | 1 ± 0 | 1 ± 0* | 0.50 ± 0.55 | 0 ± 0 | 0 ± 0 |
Note: compared with the model control group.
P < 0.01.
P < 0.05.